Privately-held dermatology specialist LEO Pharma today revealed robust growth and significantly improved profitability, ...

Japanese drugmaker Eisai today announced that its in-house-discovered and developed orexin receptor antagonist Dayvigo (brand ...

Australia’s Neurizon Therapeutics saw its shares rise 10% to A$0.16 today. after it revealed that it has been informed by the ...

Brazil’s Fiocruz, through the Drug Technology Institute (Farmanguinhos), and the pharmaceutical company EMS have signed two ...

Sweden’s Board for the Assessment of Pharmaceutical Information, NBL, has clarified the regulations for online advertising ...

Pfizer (NYSE: PFE) reported that its Phase III THRIVE-131 study of inclacumab, an experimental P-selectin inhibitor for ...

AstraZeneca (LSE: AZN) has launched FluMist Home, the first FDA-approved influenza vaccine program that allows self- or ...

Japan’s Mochida Pharmaceutical has announced that Lialda (mesalazine 600mg) the will be launched on September 8, 2025, as the NHI (National Health Insurance) Drug Price was listed on August 14, 2025.

Last week, PureTech Health spun out a new company, Celea Therapeutics, which will develop its pulmonary fibrosis candidate ...

Denmark’s Novo Nordisk scored a significant regulatory win for GLP-1 drug Wegovy (semaglutide), as the US Food and Drug ...

The US Food and Drug Administration (FDA) has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults ...

Shares of New Jersey, USA-based Tonix Pharmaceuticals rose 15.5% to $59.31 in after-hours trading on Friday, after the ...